What if a tumor's hidden dependence on Ras could become its biggest vulnerability? In this episode, Dr. Stephanie Grace Spurgeon and Dr. Cynthia Hawkins explain how their team engineered a targeted biologic to shut down Ras signaling in diffuse midline glioma—and what their preclinical findings reveal about reaching these aggressive tumors, including disease that spreads beyond the brainstem. Could this approach open a new path toward treatment? Listen to find out.
Interviewer: Dr. Jiasen He Guests: Drs. Stefanie-Grace Sbergio, Cynthia Hawkins, Jiasen He
Podden och tillhörande omslagsbild på den här sidan tillhör
Neuro-Oncology. Innehållet i podden är skapat av Neuro-Oncology och inte av,
eller tillsammans med, Poddtoppen.
